Liver Failure, AcuteLiver FailureLiver TransplantationLiver, ArtificialAcetaminophenHepatic EncephalopathyLiver DiseasesDrug-Induced Liver InjuryAnalgesics, Non-NarcoticLiverSorption DetoxificationGalactosamineLiver Function TestsLiver CirrhosisTreatment OutcomeLiver NeoplasmsSurvival RateRetrospective StudiesEnd Stage Liver DiseaseLiver RegenerationMortalityTime FactorsHepatocytesHyperammonemiaMushroom PoisoningGraft SurvivalBilirubinDrug OverdoseKeratin-18Alanine TransaminaseSurvival AnalysisHepatectomyWaiting ListsGraft RejectionLiving DonorsImmunosuppressive AgentsFatal OutcomeHeart FailurePrognosisFatty LiverPostoperative ComplicationsFollow-Up StudiesIntracranial HypertensionTissue DonorsHepatitis, AutoimmuneKidney TransplantationAcute DiseaseExtracorporeal CirculationHepatitisLiver CirculationIntracranial PressureTacrolimusProspective StudiesArtificial OrgansRisk FactorsAmmoniaMicrosomes, LiverMultiple Organ FailureCell SurvivalHepatolenticular DegenerationTissue and Organ ProcurementAspartate AminotransferasesTransaminasesSeverity of Illness IndexDisease Models, AnimalCohort StudiesCross CirculationRisk AssessmentHospital MortalityHepatic VeinsHepatitis, Viral, HumanBiological MarkersMitochondria, LiverNecrosisPredictive Value of TestsTransplantation, HomologousTransplantationTransplantsCarcinoma, HepatocellularKaplan-Meier EstimateHepatitis BExplosive AgentsLiver Cirrhosis, AlcoholicPlasma ExchangeBrain EdemaProthrombin TimeProportional Hazards ModelsTreatment FailureCause of DeathRecurrenceVitamin D-Binding ProteinImmunosuppressionDisease-Free SurvivalPortal VeinMice, Inbred C57BLLiver Diseases, AlcoholicIncidenceUnited StatesInfant, NewbornAcetylcysteine